Lupin (LUPIN) Share Price falls 2.41%: Lupin slips to Rs 2,093.05 today
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Lupin Share Price declined today as Lupin traded at Rs 2,093.05, down 2.41% from the previous close, with market capitalisation at Rs 98,069.81 crore. The move keeps Lupin Share Price Today in focus for readers tracking Lupin Stock News, especially because the supplied data confirms a clear same-day price fall but does not establish a company-specific catalyst.
The stock opened at Rs 2,091, touched a day high of Rs 2,093.15 and a day low of Rs 2,085.60. That places the session close to the opening range and slightly below the previous close of Rs 2,144.70. The turnover stood at Rs 0.27 crore. For investors following Lupin Share Price and Lupin Share Price Today, today’s decline is best read as an event-led price move rather than a story with a verified trigger. Univest is tracking the stock through this market update so readers can place the fall in context, review the financial metrics and compare the valuation with the healthcare universe.
Lupin (LUPIN) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,093.05 |
| Previous Close | Rs 2,144.7 |
| Today's Move | -Rs 51.65 (-2.41%) |
| Open | Rs 2,091 |
| High | Rs 2,093.15 |
| Low | Rs 2,085.6 |
| Turnover | Rs 0.27 crore |
| Market Capitalisation | Rs 98,069.81 crore |
| Market Cap Category | Large Cap |
Lupin Share Price Today shows a decline from Rs 2,144.70 to Rs 2,093.05, a day change of Rs -51.65 or -2.41%. The session opened at Rs 2,091 and stayed within a narrow intraday band, with the day high at Rs 2,093.15 and the day low at Rs 2,085.60. That makes today’s price action easy to read from the supplied numbers: the stock moved lower versus the prior close, but traded very close to the day’s opening level throughout the session.
The market-cap category is Large Cap, and the company’s market capitalisation is Rs 98,069.81 crore. The fall in Lupin Share Price is therefore being observed in a large listed healthcare company rather than a smaller counter. The supplied data confirms the price event and the trading range, but it does not establish a company-specific catalyst. For readers scanning Lupin Stock News or Lupin Share News, the key takeaway is the exact arithmetic: lower by Rs 51.65 on the day, with the close near the session band and turnover at Rs 0.27 crore. This sets up the stock for valuation and sector context, which is where the broader picture becomes more useful for Lupin Share Price analysis.
Lupin (LUPIN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 98,069.81 crore |
| P/E Ratio | 17.74x |
| P/B Ratio | 4.12x |
| ROE | 27.11% |
| ROCE | 28.86% |
| EPS | Rs 120.91 |
| Book Value Per Share | Rs 520.51 |
| Dividend Yield | 0.84% |
Lupin Fundamental Analysis places today’s Lupin Share Price move against a market capitalisation of Rs 98,069.81 crore and an enterprise scale that is consistent with a large listed pharma business. The stock trades at a P/E ratio of 17.74 and a P/B ratio of 4.12. Its ROE is 27.11% and ROCE is 28.86%, both of which are useful profitability measures when assessing the current Lupin Share Price.
EPS stands at Rs 120.91, while book value is Rs 520.51 per share. Dividend yield is 0.84%. These figures matter because EPS captures earnings attributable to each share, book value shows the accounting net worth behind each share, and dividend yield reflects the historical payout relative to the current price. In addition, the combination of a sub-sector-median P/E and stronger return ratios gives the stock a distinct profile within Lupin Stock Analysis. Univest readers comparing Lupin Share Price Today with company fundamentals will notice that the current valuation is not isolated from operating quality; it is tied to the exact financial numbers supplied here. That makes Lupin Share Price a useful case study for investors reviewing price action alongside financial analysis.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 17.74x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 4.12x |
| Benchmark Median P/B | 3.08x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 27.11% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.25% |
| Company ROCE | 28.86% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 12.93% |
| Company Market Capitalisation | Rs 98,069.81 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
| Benchmark Average Market Cap | Rs 13,926.75 crore |
Lupin Share Price should also be read against the Healthcare sector and the Pharmaceuticals & Drugs industry. The benchmark scope is the same industry, covering 204 companies. Within that set, Lupin’s P/E of 17.74 is below the industry median of 32.87 and the average of 48.77. Its P/B of 4.12 is above the median of 3.08 but slightly below the average of 4.31. ROE at 27.11% is well above the industry median of 11.70% and average of 10.25%, while ROCE at 28.86% is above the median of 13.46% and average of 12.93%.
The benchmark market capitalisation median is Rs 701.78 crore and the average is Rs 13,926.75 crore, compared with Lupin’s Rs 98,069.81 crore. That places the company well above the typical industry size in the supplied sample. Sector analysis therefore adds important context to Lupin Share Price Today: the stock is valued lower than many industry peers on P/E, yet it carries stronger return metrics than the benchmark median and average. In Lupin Stock News terms, that combination often draws attention because the current share price fall is happening within a business that already sits on a very different valuation and profitability base from the broader peer set.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Among the supplied peers, Lupin’s market capitalisation of Rs 98,069.81 crore is close to Dr. Reddy’s Laboratories at Rs 97,749.41 crore and above Mankind Pharma at Rs 95,743.85 crore, while still below Zydus Lifesciences at Rs 115,012.19 crore and Cipla at Rs 110,793.75 crore. It is far smaller than Sun Pharmaceutical Industries at Rs 440,397.93 crore, Divi’s Laboratories at Rs 248,664.42 crore and Torrent Pharmaceuticals at Rs 182,738.23 crore.
On valuation, Lupin’s P/E of 17.74 is lower than all supplied peers listed here, including Zydus at 25.48, Cipla at 32.87, Sun Pharma at 36.41, Dr. Reddy’s at 30.34 and the higher-multiple names Divi’s, Torrent and Laurus Labs. Lupin’s ROE of 27.11% is higher than the supplied peer set, and ROCE of 28.86% also stands above every peer shown. For readers following Lupin Stock Analysis, the peer view shows that Lupin Share Price is moving lower today despite valuation and return metrics that compare favourably within the group. That is why the stock remains relevant in Lupin Share Price News and broader healthcare sector tracking on Univest.
Why Investors Are Watching Lupin
- Lupin Share Price fell 2.41% today to Rs 2,093.05 after closing at Rs 2,144.70 previously.
- The stock traded between Rs 2,085.60 and Rs 2,093.15 during the session, with opening price at Rs 2,091.
- Market capitalisation stands at Rs 98,069.81 crore, and the company is classified as a Large Cap.
- P/E is 17.74, P/B is 4.12, ROE is 27.11% and ROCE is 28.86%.
- In the supplied peer set, Lupin’s P/E is below the listed healthcare comparables, while ROE and ROCE are higher.
About Lupin
Lupin operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied data places it in a large listed company bracket with a market capitalisation of Rs 98,069.81 crore. In today’s market update, the company appears as part of a structured pharmaceutical peer set that includes Sun Pharmaceutical Industries, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Cipla, Laurus Labs, Aurobindo Pharma, Dr. Reddy’s Laboratories and Mankind Pharma That classification is useful for Lupin Share Price Today readers because it clarifies the industry context around the current move. Univest is using the exact supplied data to keep the analysis factual and comparison-led, without adding assumptions beyond the company, sector and industry fields provided.
Track Lupin Share Price on Univest
Use Lupin (LUPIN) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Lupin Share Price on Univest for live price updates, financial ratios, market capitalisation, 52-week levels, company news and comparison with peers. Univest also helps readers monitor Lupin Share Price Today alongside valuation, fundamentals and sector context in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Lupin Share Price falling today?
Ans. Lupin Share Price is lower by 2.41% today, trading at Rs 2,093.05 versus the previous close of Rs 2,144.70. The supplied data confirms the fall but does not establish a company-specific catalyst.
What is Lupin Share Price Today?
Ans. Lupin Share Price Today is Rs 2,093.05. The stock opened at Rs 2,091, hit a day high of Rs 2,093.15 and a day low of Rs 2,085.60, keeping the session tightly contained.
What is Lupin’s market capitalisation?
Ans. Lupin’s market capitalisation is Rs 98,069.81 crore. The company is classified as a Large Cap, which provides size context when reading today’s share price fall and peer comparisons. The company operates in the Healthcare sector.
How does Lupin compare on valuation?
Ans. Lupin trades at a P/E of 17.74 and a P/B of 4.12. In the supplied industry benchmark, its P/E is below the median and average, while its P/B is slightly above the median.
What do Lupin’s ROE and ROCE show?
Ans. Lupin’s ROE is 27.11% and ROCE is 28.86%. Both are above the supplied industry median and average, which adds important context to Lupin Share Price when compared with peers and sector benchmarks.
How do Lupin’s EPS and book value matter?
Ans. EPS is Rs 120.91 and book value is Rs 520.51 per share. EPS reflects earnings attributable to each share, while book value shows accounting net worth behind each share, both useful in Lupin Share Price analysis.
What is Lupin’s dividend yield?
Ans. Lupin’s dividend yield is 0.84%. This is historical and current data, not a payout guarantee, but it remains a useful part of the overall Lupin Share Price and fundamental context.
